𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer

✍ Scribed by S.J. Otto; S.M. Moss; L. Määttänen; M. Roobol; M. Zappa; V. Nelen; M. Kwiatkowski; A. Villers; J. Hugosson; A. Berenguer Sanchez; H.J. de Koning


Book ID
116430546
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
230 KB
Volume
46
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Detection rates of high-grade prostate c
✍ Theodorus H. van der Kwast; Stefano Ciatto; Paula M. Martikainen; Robert Hoedema 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 137 KB 👁 1 views

## Abstract Screening for prostate cancer using prostate‐specific antigen (PSA) tests has led to a stage and grade shift as compared to the pre‐PSA era. Effectiveness of screening for prostate cancer should be manifested by a reduction in detection rate of aggressive cancers during subsequent scree

PSA doubling time predicts the outcome a
✍ Khatami Ali; Aus Gunnar; Damber Jan-Erik; Lilja Hans; Lodding Pär; Hugosson Jona 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 127 KB 👁 2 views

## Abstract This study reports the outcome of active surveillance in men with PSA screening‐detected prostate cancer (PC), and PSA doubling time (PSADT) was evaluated as a predictor of selecting patients to active treatment or surveillance. On December 31, 1994, 10,000 men were randomized to bienni

Effective PSA contamination in the Rotte
✍ Suzie J. Otto; Ingrid W. van der Cruijsen; Michael K. Liem; Ida J. Korfage; Jan 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 93 KB 👁 2 views

## Abstract The extent of effective prostate‐specific antigen (PSA) contamination in the Rotterdam section of the ongoing European Randomized Study of Screening for Prostate Cancer (ERSPC) trial was evaluated and defined as when opportunistic PSA testing of ≥ 3.0 ng/ml was followed by biopsy, simil